We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock
SILK

Delisted

SILK was delisted on the 16th of September, 2024.

Back to rankings

154 hedge funds and large institutions have $778M invested in Silk Road Medical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

563% more call options, than puts

Call options by funds: $25.3M | Put options by funds: $3.81M

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

49% more capital invested

Capital invested by funds: $521M → $778M (+$257M)

27% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 41

16% more funds holding

Funds holding: 133 → 154 (+21)

Holders
154
Holders Change
+21
Holders Change %
+15.79%
% of All Funds
2.22%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
38
Increased
52
Reduced
41
Closed
17
Calls
$25.3M
Puts
$3.81M
Net Calls
+$21.5M
Net Calls Change
+$21.1M

Top Buyers

Rank Fund Capital Flow
1
SI
Sofinnova Investments
California
+$18.9M
2
TLP
Tri Locum Partners
New York
+$17.2M
3
KCM
Kennedy Capital Management
Missouri
+$16.4M
4
TCM
TimesSquare Capital Management
New York
+$10.7M
5
WA
Wasatch Advisors
Utah
+$7.94M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$25.7M
2
JFG
Jefferies Financial Group
New York
-$24.5M
3
Goldman Sachs
Goldman Sachs
New York
-$18.3M
4
RCMNY
Rubric Capital Management (New York)
New York
-$17.5M
5
AC
Armistice Capital
New York
-$12.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
NC
126
nVerses Capital
Florida
$29.3K +$25.4K +1,600 New
AB
127
Amalgamated Bank
New York
$24K -$65.8K -4,145 -76%
HBW
128
Hazlett, Burt & Watson
West Virginia
$21K – – –
AF
129
Advisornet Financial
Minnesota
$20.9K -$49.9K -3,145 -73%
US Bancorp
130
US Bancorp
Minnesota
$18.4K – – –
Federated Hermes
131
Federated Hermes
Pennsylvania
$18.3K -$7.47M -470,776 -100%
TRCT
132
Tower Research Capital (TRC)
New York
$16.3K -$110K -6,946 -89%
QCG
133
Quadrant Capital Group
Ohio
$9.51K – – –
CFM
134
Catalyst Funds Management
Australia
$3.66K +$3.17K +200 New
PA
135
PSI Advisors
Florida
$3.57K – – –
LC
136
Lindbrook Capital
California
$3K – – –
AW
137
Avion Wealth
Texas
$2K – – –
VNA
138
Valley National Advisers
Pennsylvania
$2K +$2.14K +135 New
EWA
139
EverSource Wealth Advisors
Alabama
$1.65K – – –
FFA
140
Farther Finance Advisors
California
$1.62K -$1.57K -99 -52%
SPIA
141
Steward Partners Investment Advisory
New York
$1.56K – – –
VCM
142
Versant Capital Management
Arizona
$1.21K – – –
S
143
SignatureFD
Georgia
$824 +$714 +45 New
CTC
144
Central Trust Company
Missouri
$788 – – –
Comerica Bank
145
Comerica Bank
Texas
$788 – – –
AF
146
Allworth Financial
California
$312 +$270 +17 New
MCM
147
Manchester Capital Management
Vermont
$239 +$206 +13 New
GI
148
GAMMA Investing
California
$165 +$143 +9 New
AWM
149
Avior Wealth Management
Nebraska
$146 +$127 +8 New
HGERS
150
Householder Group Estate & Retirement Specialist
Arizona
$128 – – –
3 4 5
6
7

SILK Hedge Fund Activity: Q1 2024 in Review

154 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q1 2024, worth a combined $778M — up 49% from $521M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new SILK positions and 17 closed out — a net gain of 21 holders — while 52 added to existing stakes and 41 trimmed.

The largest buyer was Sofinnova Investments, opening a new position worth an estimated $18.9M. The largest seller was Morgan Stanley, cutting an estimated $25.7M.

  • 154 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q1 2024, up from 133 in Q4 2023.
  • Funds reported $778M of Silk Road Medical, Inc. Common Stock stock for Q1 2024, up 49% quarter-over-quarter.
  • 38 funds opened new Silk Road Medical, Inc. Common Stock positions in Q1 2024 and 17 closed out, a net change of +21 holders.
  • The largest Silk Road Medical, Inc. Common Stock buyer in Q1 2024 was Sofinnova Investments, an estimated $18.9M added.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $25.7M sold.

Based on aggregated 13F filings for Q1 2024.